Pembrolizumab for anaplastic thyroid cancer: a case study.
Aghajani MJ, Cooper A, McGuire H, Jeffries T, Saab J, Ismail K, de Souza P, Bray V, Fazekas de St Groth B, Niles N, Roberts TL.
Aghajani MJ, et al.
Cancer Immunol Immunother. 2019 Dec;68(12):1921-1934. doi: 10.1007/s00262-019-02416-7. Epub 2019 Oct 22.
Cancer Immunol Immunother. 2019.
PMID: 31637475
Free PMC article.